Using genomic information and artificial intelligence, researchers have developed a saliva test to predict the risk of complications of the disease before the first symptoms appear.
In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’
With its reduced injection frequency, insulin icodec (Awiqli) has the potential to provide better adherence and greater treatment satisfaction in some patients.
The FDA will permit dairy companies to say that eating yogurt regularly may reduce the risk of Type 2 diabetes, according to limited scientific evidence.
